At least this should create some interesting banter between the bulls and the bears
Printable View
At least this should create some interesting banter between the bulls and the bears
Going to put some into this, might end up with a good high in green or left with just sinking red eyes
From the PDS, Cannasouth will have an implied market capitalisation post IPO of $46m - $51m yet has no revenue or even products?!?
The lucky wholesale investors who invested in August stand to make a 6.4x return in 9 months! While the poor investors who waited a month, stand only to make a 2x return in 8 months....!
Madness :ohmy:Quote:
Summary of Capital Raising Initiatives and Commercial Milestones
• in August 2018, Cannasouth undertook its first external capital raising where
it raised $1.2 million at a pre-investment valuation of $5 million from several
“wholesale investors” (as that term is defined in the Financial Markets Conduct
Act); and
• in October 2018, Cannasouth undertook its second external capital raising,
where it raised $2.5 million at a pre-investment valuation of $18 million from
approximately 38 “wholesale investors” (as that term is defined in the Financial
Markets Conduct Act).
It used to be tulips.... now its dope..... :)
Not madness at all, ask yourself why the wholesale (early) investors agreed to IPO? Surely not to get rich(er)? either way they win, by selling into the post IPO euphoria or by holding shares that are are 10 baggers.
Sort of like private equity floats, or back door promoters, they expect pretty much instant returns of 10x+ multiples and it's the dumb f*ck punters who fund it.
And you're right, no product, no revenue and they're a biotech research company. May never be any products, let alone whether any one wants to buy them if they do have products.
And for that reason, I'm out.
Edit: or the ability for production at scale, sales, marketing, distribution ... so many unknowns.
Actually technically thats not right, since post IPO valuation includes dilution of existing shares. $46-51 million includes the raised $5-10 million. So valuation before dilution is $41 million
August raise is calculated at $5 million valuation + $1.2 million raise = $6.2 million valuation after raise = 41/ 6.2 = 6.6x
October raise is $18 million + $2.5 million = $20.5 million = 41/20.5 = 2x
Still massive gains but not as high as you originally though, though comes with the risk thats why the gains are higher. Its only great when you win, but you'll also have to consider how many other investments that don't make it and to justify the risk they have to give a high reward. By no means do I think the valuation is worth it given no revenues and no ideal future prospects yet, though markets are not rational and think about the big possibilities that could happen.
...What I found interesting is the low amounts the directors are currently paid.
Anthony Ho - $40,000
Conor English - $40,000
Mark Lucas - $80,000
Nic Foreman - $80,000
Furthermore
"No prospective financial information provided"
"Cannasouth has yet to generate any revenue as at the date of this PDS, andhas no contractual arrangements in place which provide for the generation offuture revenues"
Can some one post Brian Gaynors Saturday N Z Herald business column, not too flattering comments me thinks and only for the very very very brave imho !!!
buyer beware imo.
Tim Preston, Sean Joyce and John Sorensen .............. not much else you really need to know....